Snowball logo
logo
HALO_logo

Halozyme Therapeutics, Inc

$100.67-$1.12Β  (1.1%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
443.3660.1829.31,015.31,396.61,663.7
COGS
81.41139.3192.4159.4305.4363.1
Gross Profit
361.9520.8636.9855.91,091.21,300.7
Operating Expenses & Income
Operating Income
275.9267.5337.6551.5816.3944.5
Total Operating Expenses
86253.3299.3304.4274.9356.2
R&D Expenses
35.6766.6176.3679.0581.49102.4
Selling General & Admin Expenses
50.32143.5149.2154.3207.1181
Earnings from Continuing Operations
Interest Expense
(7.526)(16.95)(18.76)(18.09)(18.13)(20.3)
Interest Income
------
Income Tax Expense
(154.2)46.7966.73113150169.7
Net Income
Net Income
402.7202.1281.6444.1316.9413.6
Supplemental
EBIT
275.9265.9367.1575.2485-
EBITDA
278.9315.5451.9656.5573.1681.7
In millions of USD, except % and values per 1 share